Dr. Okhuysen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
The University of Texas MD Anderson Cancer Center
1515 Holcombe, Unit 1460
Houston, TX 77030Phone+1 713-745-8413Fax+1 713-745-6839- Is this information wrong?
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1991 - 1994
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1989 - 1991
- Cook County Health and Hospitals SystemInternship, Internal Medicine, 1988 - 1989
- Universidad de GuadalajaraClass of 1988
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- WA State Medical License 2023 - 2024
- MS State Medical License 2023 - 2024
- AL State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Join now to see all
Clinical Trials
- An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy Start of enrollment: 2020 Oct 07
Publications & Presentations
PubMed
- A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes ...Okhuysen, P., Ramesh, M., Louie, T., Kiknadze, N., Torre-Cisneros, J., de Oliveira, C., Van Steenkiste, C., Stychneuskaya, A., Garey, K., Garcia-Diaz, J., Li, J., Dupe...> ;Clinical Infectious Diseases. 2024 Feb 2
- Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications.Murphy, B., Dailey Garnes, N., Hwang, H., Peterson, C., Garey, K., Okhuysen, P.> ;The Pediatric Infectious Disease Journal. 2023 Dec 21
- 1 citationsModulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial.Xiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, Johannes F Fahrmann, Fangyu Li, Yongwoo David Seo, Gladys J Browman, Jennifer B Dennison, Jody Vykoukal, Pamela N Luna...> ;Ebiomedicine. 2023 Dec 1
- Join now to see all
Press Mentions
- Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer TherapyOctober 7th, 2020
- Grant Funds Mucosal Infection Research at BaylorApril 18th, 2019
Grant Support
- Gene Polymorphisms Predisposing To Infectious DiarrheaNational Institute Of Allergy And Infectious Diseases2003–2007
- IL-2 (PROLEUKIN) In HIV+ Patients In A Randomized International Trial (ESPRIT)National Center For Research Resources2005
- Comparison Of The Clinical Consequences Of Two Anti-Retroviral Regimens In HIVNational Center For Research Resources2005
- Ucrc Special Case Study ProtocolNational Center For Research Resources2004–2005
- Infectivity Of Cryptosporidium Parvum For Adult HumansNational Center For Research Resources1998–2005
- IL-2 (PROLEUKIN) In HIV+ Patients In A Randomized TrialNational Center For Research Resources2004
- Infectivity Of Cryptosporidium Parvumfor Adult HumansNational Center For Research Resources1999–2002
- Arginine Aminopeptidases Of Cryptosporidium ParvumNational Center For Research Resources1996–1999
Professional Memberships
- Member
- Fellow
- Member
- Fellow
Other Languages
- Spanish
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: